Shopping Cart
Remove All
Your shopping cart is currently empty
L-365260 is an orally available, selective and potent nonpeptide gastrin and cerebral cholecystokinin receptor (CCK-B) antagonist.L-365260 inhibits CCK-8S-induced increase in [Ca2+]i, blocks stress-induced hypersensitivity in viscera, and blocks the anti-exploratory effect of CCK-4.L-365260 has been used in the study of neurological Ojibwa and endocrine diseases.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 2 mg | $149 | - | In Stock |
| Description | L-365260 is an orally available, selective and potent nonpeptide gastrin and cerebral cholecystokinin receptor (CCK-B) antagonist.L-365260 inhibits CCK-8S-induced increase in [Ca2+]i, blocks stress-induced hypersensitivity in viscera, and blocks the anti-exploratory effect of CCK-4.L-365260 has been used in the study of neurological Ojibwa and endocrine diseases. |
| Targets&IC50 | Gastrin:1.9 nM (Ki), Gastrin/CCK-B:2.0 nM (Ki) |
| In vitro | L-365260 is a compound with high affinity for CCK-B receptors in the brains of various species, which significantly attenuates CCK8S- and CCK4-mediated neuronal depolarization, and has lower affinity for CCK-B and gastrin receptors in dog tissues[1]. |
| In vivo | In male Sprague-Dawley rats (300-350 g), L-365260 (0.01, 0.05, 0.1, 0.2, 0.75, 1.0, 10.0 mg/kg; subcutaneous injection) enhances the analgesic effects[3]. |
| Synonyms | L365260, L-365,260, L 365260 |
| Molecular Weight | 398.46 |
| Formula | C24H22N4O2 |
| Cas No. | 118101-09-0 |
| Smiles | CN1c2ccccc2C(=N[C@@H](NC(=O)Nc2cccc(C)c2)C1=O)c1ccccc1 |
| Relative Density. | 1.23g/cm3 |
| Storage | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | Ethanol: <39.85 mg/mL, Sonication is recommended. DMSO: 80 mg/mL (200.77 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
| In Vivo Formulation | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 3.3 mg/mL (8.28 mM), Sonication is recommended. Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.